Egypt’s Rameda gets requests to export COVID-19 drug -CEO – ZAWYA

Egypt’s Rameda gets requests to export COVID-19 drug -CEO – ZAWYA

Egypt's Rameda gets requests to export COVID-19 drug -CEO Egypt's Rameda gets requests to export COVID-19 drug -CEO | ZAWYA MENA Edition HomeBusinessArticleEgypt's Rameda gets requests to export COVID-19 drug -CEO The company is providing the drug to the Egyptian health ministry to be used in hospitals    Medicine are arranged on a shelf inside in a pharmacy in Cairo, Egypt, November 17, 2016. Picture taken November 17, 2016. REUTERS/Mohamed Abd El Ghany ALEXANDRIA, Egypt - Egypt's Rameda Pharmaceutical RMDA.CA has received requests to export Anviziram tablets, which are used to treat patients with the new coronavirus, to Saudi Arabia, Kuwait, Iraq and Yemen, but needs a government approval first, its CEO told Reuters.The company said earlier this month it had started manufacturing Anviziram, the generic equivalent of the Japanese antiviral Avigan, and had also received an approval from the Egyptian Drug Authority to manufacture Remedsivir, a Gilead Sciences Inc GILD.O antiviral used for treating COVID-19.Rameda, which listed 49% of its shares on the Egyptian exchange last year, has produced quantities enough Anviziram tablets to cover "appropriate numbers of patients in the Egyptian market," said its CEO Amr Morsy.The company said earlier this month it had started manufacturing Anviziram, the